A*STAR researchers have identified specific sites in the surface protein of influenza viruses that allow the pathogen to adapt to different host organisms.
The host immune system has a limited impact on the evolution of the influenza virus, A*STAR researchers find.
Infiltrating self-defense cells provoke kidney failure in a chronic autoimmune disease
A biosensor capable of sensitively detecting influenza viruses has potential for improving clinical diagnosis of Influenza A
A more efficient production process for influenza vaccines could help to cope with future pandemics
A decade after the opening of Biopolis, Singapore’s premier biomedical sciences research hub, A*STAR’s multifaceted activities are spurring discovery and innovation with a global reach
A*STAR’s new vaccine, based on a virus-like particle technology created by Cytos Biotechnology AG, could strengthen Singapore’s ability to tackle influenza pandemics
A computational algorithm for tracking influenza viral ancestry outperforms even human experts
A silicon-based microfluidic chip that distinguishes different viral strains shows potential for the quick on-site diagnosis of infectious diseases
A strain of H1N1 influenza virus that rapidly develops resistance to the antiviral drug oseltamivir has emerged
An innovative system for detecting and identifying the viruses responsible for infectious disease should facilitate decentralized screening of suspect cases